Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSC
4476
DELISTED
TriState Capital Holdings, Inc.
TSC
| $355K | ﹤0.01% |
12,859
+11,223
| +686% | +$321K |
|
|
QADA
4477
DELISTED
QAD Inc.
QADA
| $355K | ﹤0.01% |
6,254
+4,621
| +283% | +$252K |
|
4478
CALL
Aon
AON
$75.7B
| $354K | ﹤0.01% |
2,300
-5,800
| -72% | -$848K |
|
4479
MacroGenics
MGNX
$259M
| $354K | ﹤0.01% |
16,507
+13,637
| +475% | +$291K |
|
|
QHC
4480
DELISTED
Quorum Health Corporation
QHC
| $354K | ﹤0.01% |
60,453
+29,261
| +94% | +$134K |
|
4481
Comstock Resources
CRK
$3.99B
| $353K | ﹤0.01% |
42,305
+16,587
| +64% | +$155K |
|
|
EGC
4482
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
| $353K | ﹤0.01% |
42,308
-189,938
| -82% | -$1.66M |
|
4483
Suburban Propane Partners
SPH
$1.17B
| $351K | ﹤0.01% |
14,905
-5,899
| -28% | -$138K |
|
4484
PUT
Xylem
XYL
$28.1B
| $351K | ﹤0.01% |
4,400
-700
| -14% | -$52.3K |
|
|
AVEO
4485
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $351K | ﹤0.01% |
+10,600
| New | +$272K |
|
|
BLUE
4486
PUT
DELISTED
bluebird bio
BLUE
| $350K | ﹤0.01% |
185
-942
| -84% | -$1.95M |
|
4487
British American Tobacco
BTI
$124B
| $350K | ﹤0.01% |
7,498
-2,769
| -27% | -$141K |
|
|
SBBP
4488
DELISTED
Strongbridge Biopharma plc.
SBBP
| $350K | ﹤0.01% |
72,240
+16,469
| +30% | +$84.3K |
|
|
TAST
4489
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $349K | ﹤0.01% |
23,876
+17,123
| +254% | +$260K |
|
4490
PUT
Amphenol
APH
$204B
| $348K | ﹤0.01% |
14,800
+8,800
| +147% | +$205K |
|
|
SP
4491
DELISTED
SP Plus Corporation
SP
| $348K | ﹤0.01% |
9,515
+756
| +9% | +$29.1K |
|
4492
Agios Pharmaceuticals
AGIO
$2B
| $347K | ﹤0.01% |
4,496
-85
| -2% | -$6.84K |
|
4493
PUT
Olin
OLN
$2.17B
| $347K | ﹤0.01% |
13,500
-1,800
| -12% | -$52.8K |
|
4494
Voyager Therapeutics
VYGR
$198M
| $347K | ﹤0.01% |
18,299
+1,430
| +8% | +$27.4K |
|
4495
BioCryst Pharmaceuticals
BCRX
$2.51B
| $345K | ﹤0.01% |
45,148
+34,050
| +307% | +$229K |
|
4496
PUT
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $345K | ﹤0.01% |
10,100
-112,600
| -92% | -$3.85M |
|
|
ATNX
4497
DELISTED
Athenex, Inc. Common Stock
ATNX
| $345K | ﹤0.01% |
1,111
+957
| +621% | +$337K |
|
4498
1st Source
SRCE
$2.13B
| $343K | ﹤0.01% |
6,507
+5,270
| +426% | +$294K |
|
|
CNR
4499
Core Natural Resources Inc
CNR
$4.64B
| $343K | ﹤0.01% |
8,414
-61,608
| -88% | -$2.59M |
|
4500
CALL
Synaptics
SYNA
$4.2B
| $342K | ﹤0.01% |
7,500
-1,600
| -18% | -$76.1K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.